SII

Hyderabad: Pfizer and the Serum Institute of India (SII) had already sought emergency use approval for their COVID-19 vaccines from the Drug Controller General of India (DCGI). Now,…

Pune: Serum Institute of India’s (SII) phase 2 trial of Oxford's COVID-19 vaccine candidate is set to commence on Tuesday. The determination of safety and immunogenicity of “Covishield”…

Pune: Animal trials for a vaccine for the coronavirus pandemic are already underway. The vaccine will be available but only within a year. However, it is not likely to be 100% effective.…